AT343817B - Verfahren zur herstellung von pyrazolone und gegebenenfalls coffeinverbindungen enthaltenden, mechanisch stabilen und haltbaren tabletten - Google Patents
Verfahren zur herstellung von pyrazolone und gegebenenfalls coffeinverbindungen enthaltenden, mechanisch stabilen und haltbaren tablettenInfo
- Publication number
- AT343817B AT343817B AT884773A AT884773A AT343817B AT 343817 B AT343817 B AT 343817B AT 884773 A AT884773 A AT 884773A AT 884773 A AT884773 A AT 884773A AT 343817 B AT343817 B AT 343817B
- Authority
- AT
- Austria
- Prior art keywords
- coffein
- pyrazolones
- compounds
- producing
- mechanically stable
- Prior art date
Links
- 229940051880 analgesics and antipyretics pyrazolones Drugs 0.000 title 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical class CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2251199A DE2251199C3 (de) | 1972-10-19 | 1972-10-19 | Verfahren zur Herstellung von Pyrazolone enthaltenden Tabletten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA884773A ATA884773A (de) | 1977-10-15 |
| AT343817B true AT343817B (de) | 1978-06-26 |
Family
ID=5859451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT884773A AT343817B (de) | 1972-10-19 | 1973-10-18 | Verfahren zur herstellung von pyrazolone und gegebenenfalls coffeinverbindungen enthaltenden, mechanisch stabilen und haltbaren tabletten |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5217086B2 (de) |
| AT (1) | AT343817B (de) |
| BE (1) | BE806290A (de) |
| DE (1) | DE2251199C3 (de) |
| DK (1) | DK144872C (de) |
| ES (1) | ES419603A1 (de) |
| FR (1) | FR2247207B1 (de) |
| GB (1) | GB1446237A (de) |
| NL (1) | NL180477C (de) |
| ZA (1) | ZA738102B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0243521A1 (de) * | 1986-04-30 | 1987-11-04 | Werner Prof. Dr. Thorn | Oral verabreichbares Präparat |
| JP2682353B2 (ja) * | 1991-11-20 | 1997-11-26 | 武田薬品工業株式会社 | 経口用医薬組成物およびその製造法 |
| TW284688B (de) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd |
-
1972
- 1972-10-19 DE DE2251199A patent/DE2251199C3/de not_active Expired
-
1973
- 1973-10-12 NL NLAANVRAGE7314098,A patent/NL180477C/xx not_active IP Right Cessation
- 1973-10-13 ES ES419603A patent/ES419603A1/es not_active Expired
- 1973-10-18 AT AT884773A patent/AT343817B/de not_active IP Right Cessation
- 1973-10-18 ZA ZA00738102A patent/ZA738102B/xx unknown
- 1973-10-18 DK DK565873A patent/DK144872C/da not_active IP Right Cessation
- 1973-10-18 FR FR7337172A patent/FR2247207B1/fr not_active Expired
- 1973-10-19 GB GB4883773A patent/GB1446237A/en not_active Expired
- 1973-10-19 JP JP48117000A patent/JPS5217086B2/ja not_active Expired
- 1973-10-19 BE BE136877A patent/BE806290A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7314098A (de) | 1974-04-23 |
| DK144872B (da) | 1982-06-28 |
| DE2251199C3 (de) | 1980-04-10 |
| JPS4971131A (de) | 1974-07-10 |
| FR2247207B1 (de) | 1978-11-03 |
| NL180477B (nl) | 1986-10-01 |
| ES419603A1 (es) | 1976-07-01 |
| ATA884773A (de) | 1977-10-15 |
| DE2251199B2 (de) | 1979-08-09 |
| DE2251199A1 (de) | 1974-05-02 |
| NL180477C (nl) | 1987-03-02 |
| DK144872C (da) | 1982-11-15 |
| FR2247207A1 (de) | 1975-05-09 |
| BE806290A (fr) | 1974-04-19 |
| ZA738102B (en) | 1975-05-28 |
| GB1446237A (en) | 1976-08-18 |
| JPS5217086B2 (de) | 1977-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT341684B (de) | Verfahren zur herstellung des neuen tri-p-toluolsulfonats von s-adenosyl -l-methionin | |
| AT356809B (de) | Verfahren zur herstellung von neuen enolderivaten | |
| AT327157B (de) | Verfahren zur herstellung von dimethylather | |
| ATA583473A (de) | Verfahren zur herstellung von neuen sufonamidodiphenylathern | |
| ATA964673A (de) | Verfahren zur herstellung von neuen heptapeptiden | |
| CH549599A (de) | Verfahren zur herstellung von neuen 5-nitrofuranderivaten. | |
| CH549408A (de) | Verfahren zur herstellung von mikrogranulaten. | |
| CH551957A (de) | Verfahren zur herstellung von neuen jononderivaten. | |
| CH553797A (de) | Verfahren zur herstellung von heterocyclischen verbindungen. | |
| ATA130373A (de) | Verfahren zur herstellung von neuen benzimidazolen | |
| AT351167B (de) | Verfahren zur herstellung von allopurinol- haltigen tabletten | |
| CH558379A (de) | Verfahren zur herstellung von heterocyclischen verbindungen. | |
| CH554338A (de) | Verfahren zur herstellung von heterocyclischen verbindungen. | |
| ATA884773A (de) | Verfahren zur herstellung von pyrazolone und gegebenenfalls coffeinverbindungen enthaltenden, mechanisch stabilen und haltbaren tabletten | |
| AT327407B (de) | Verfahren zur herstellung von neuen benzomorphanderivaten | |
| CH546778A (de) | Verfahren zur herstellung von heterocyclischen verbindungen. | |
| AT326103B (de) | Verfahren zur herstellung des neuen 1-dodecylaminomethyl-2-amino-cyclopentans | |
| AT326842B (de) | Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten | |
| AT333722B (de) | Verfahren zur herstellung von diazoverbindungen | |
| AT326841B (de) | Verfahren zur herstellung von neuen 15alfa,16alfa-methylen-4-pregnenen | |
| CH555393A (de) | Verfahren zur herstellung von polyazoverbindungen. | |
| ATA971373A (de) | Verfahren zur herstellung von neuen benzimidazolderivaten | |
| AT322099B (de) | Verfahren zur herstellung von rifamycin b | |
| CH553753A (de) | Verfahren zur herstellung von neuen amidinen. | |
| ATA196973A (de) | Verfahren zur herstellung von neuen 2-amino-4,5-dihydropyridin-3,5-dicarbon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |